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Abstract 
Background:To study the prevalence of coronary 
artery disease (CAD) in patients undergoing valve 
surgery for rheumatic and non-rheumatic valvular 
heart disease. 
Methods: In this cross sectional study,  233 patients 
planned for valvular heart surgery and aged 40 years 
or more were subjected to preoperative coronary 
angiogram. Data regarding risk factors and valve 
pathology were collected. Continuous variables were 
presented as mean (SD) and categorical variables as 
frequencies. Logistic regression analysis was used to 
study predictive factors for CAD in valvular heart 
disease. 
Results: Rheumatic heart disease (RHD) was the 
commonest etiology; 56% of patients had RHD, 
while 21% had degenerative valvular heart disease. 
Mitral stenosis was the most common valve 
pathology. The overall prevalence of CAD was 
found to be 31.3% in valvular heart disease (VHD). 
CAD had a lower prevalence of 18.2% in rheumatic 
heart disease as compared to a much higher 
prevalence in degenerative valve disease (62%). 
Conclusion: CAD has lower prevalence in 
rheumatic heart disease as compared to degenerative 
valve disease. 
Key Words: Coronary artery disease, 
Atherosclerosis, Valvular heart disease, Coronary 
angiography, Rheumatic heart disease. 
 
Introduction 
The prevalence of coronary artery disease (CAD) in 
valvular heart disease varies between 9-41% in 
western population, but its prevalence in Pakistan is 
understudied. 
Valvular heart disease is a major health problem 
particularly in developing countries.1 Rheumatic heart 
disease (RHD) is the predominant etiology in 
developing countries like Pakistan. In Pakistan a high 
prevalence rate of 5.7/1000 of RHD was reported by 
echocardiographic diagnosis.2The same is a 
contributor to premature mortality and morbidity in 
Pakistan.2 
Untreated coronary artery disease (CAD) in valvular 
heart disease (VHD) patients undergoing surgery 
leads to unfavorable perioperative and long-term 
outcome, thereby mandating identification of CAD 
before going to surgery.3,4 However combined 
valvular and revascularization surgery has much 
higher mortality and morbidity as compared to valve 
surgery alone.5,6Coronary angiography (CAG) is most 
commonly used to identify CAD preoperatively. The 
incidence of CAD in VHD varies from 9% to 
41%.3,7This means indiscriminately subjecting such 
patients to CAG before surgery may be posing them to 
risk at the same time while failure to recognize and 
treat accompanying CAD will adversely affect the 
prognosis. 
ACCA- AHA guideline for coronary angiography 
(CAG) in valvular heart disease (VHD) state that CAG 
be performed in men aged 40 years or older, 
premenopausal woman aged 40 years or more who 
have coronary risk factors and post-menopausal 
women.8Guidelines have been based on limited 
studies on valvular heart disease patients.9In addition 
guidelines are based on studies conducted in western 
population where the leading cause of valvular heart 
disease is degenerative.3,9 However, in developing 
countries including Pakistan majority of VHD patients 
have rheumatic etiology.1,3,10,11The current study was 
planned with the aim to investigate the prevalence of 
coronary artery disease in patients undergoing surgery 
for VHD and if etiology of VHD has any influence on 
CAD presence. 
 
Patients and Methods 
This cross sectional study was conducted at 
Rawalpindi Institute of Cardiology, from January to 
December, 2017. Patients who underwent CAG 
(n=233) as preoperative workup for valve surgery, 
were included. Patients less than 18 years of age, with 
ischemic etiology of valvular lesion, with mild to 
moderate valvular pathology, with prosthetic valve 
dysfunction, re-operated cases, with prior balloon 
valvuloplasty, not planned for surgery and those who 
did not give consent were excluded. Written informed 
consent was taken from all patients before undergoing 
Journal of Rawalpindi Medical College (JRMC); 2018;22(4): 302-305 
 303 
coronary angiography. Data regarding cardiovascular 
risk factors was recorded. Transthoracic and 
transesophageal (where required) echocardiogram 
was performed in all patients to assess severity of 
valve lesions, etiology, non-valvular pathology and 
ventricular function. Coronary angiograms of all 
patients were reviewed. Coronaries were reported as 
normal if there was no narrowing (plaque), 
irregularity in contour or ectasia in epicardial vessels. 
Coronary artery disease (CAD) was defined as at least 
one of above. The severity of obstructive CAD was 
defined as severe if ≥ 70% stenosis in any of three 
major coronaries or their large (≥ 3mm) branches or ≥ 
50% stenosis in left main stem. Mild lesions were 
classified as < 50% narrowing and moderate stenosis 
included between 50% and less than 70% narrowing of 
vessel lumen. Hypertension was defined as systolic 
blood pressure of ≥ 140mmHg and/or diastolic blood 
pressure of ≥ 90mmHg or use of antihypertensive 
medication. Diabetes mellitus was defined as fasting 
blood glucose of 126mg/dl or use of antidiabetic 
medication. Dyslipidemia was defined as total 
cholesterol ≥ 200mg/dl and/or triglycerides ≥ 
150mg/dl.The student t-test was used for comparison 
of numerical variables and chi-square test was used 
for comparison of categorical variables. A p value of 
less than 0.05 was considered to be statistically 
significant. 
Results 
Rheumatic disease was the leading cause, present in 
56.7% (n=132) . Mean age was 50.14 +  8.79 years. 
Valve disease was found in 21.5% (n=50), whereas 
myxomatous and bicuspid valve were present in 
12.4% (n=29) and 9.4% (n=22) respectively. 
Hypertension was documented in 54%((Table 1)Mitral 
stenosis was the most common single valve pathology 
with 75 patients having it, followed by mitral 
regurgitation (67 patients), aortic stenosis (41 patients) 
and aortic regurgitation (18 patients). Whereas 32 
patients had mixed or double valve pathology (Table 
2). Overall 31.3% patients were found to have 
coronary artery disease. Out of them, majority of 
patients 80.82% had less than severe obstructive 
disease CAD including subcritical or minor coronary 
artery disease while only 13.69% (n=10) had severe 
CAD. Muscle bridge was present in four patients 
(5.47%), whereas coronary ectasia was found in one 
patient only. No patient was found to have triple 
vessel coronary artery disease in our subset of 
patients. With respect to valve pathology CAD was 
most frequent in patients with aortic stenosis (56.1%) 
followed by aortic regurgitation (44.4%). While it was 
least frequent in patients with mitral stenosis; affecting 
only 13.3% of patients with mitral stenosis (Table 3). 
Coronary artery disease was more likely to be present 
in patients with atherosclerotic risk factors. Table IV 
shows the clinical characteristics of patients with and 
without CAD. Regression analysis showed good 
correlation of CAD with risk factors (R2=0.76).  
 
Table 1:Baseline characteristics of patients 
Characteristic No(%) 
Sex (male 111(47.6) 
Hypertension 54(23.2) 
Diabetes Mellitus 34(14.6) 
Smoking 43(18.5) 
Dyslipidemia 50(21.5) 
Table 2: Type of VHD 
Type  No(%) 
Mitral stenosis 75(32.18) 
Aortic stenosis 41(17.59) 
Mitral regurgitation 67(28.75) 
Aortic 
regurgitation 
18(7.73) 
Mixed/double 32(13.73) 
 
Table 3: Coronary artery disease in patients with 
different etiologies of valvular heart disease  
Etiology Coronary 
artery disease 
present   
N(%) 
Normal 
epicardial 
coronaries  
N(%) 
Rheumatic  24(18.2) 108(81.8) 
Degenerative 31(62) 19(38) 
Bicuspid 8(36.4) 14(63.6) 
Myxomatous  10(34.5) 19(65.5) 
 
Table 4: Clinical characteristics of patients with 
and without CAD* 
Variables Patients 
 with 
CAD (n=73) 
Patients 
without 
CAD(n=160) 
p-value 
Hypertension 39(53.42) 15 (9.3) <0.001 
Diabetes mellitus 32 (43.83) 2(1.25) <0.001 
Smoking 32(43.83) 11(6.87) <0.001 
Dyslipidemia 36(49.31) 14(8.75) <0.001 
Male sex 40(54.79) 71(44.37) <0.001 
*CAD=Coronary artery disease  
 
CAD was strongly associated with presence of risk 
factors among patients with valvular heart disease 
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(p<0.001). CAD was significantly more prevalent in 
patients aged 50 years or above (40.8% versus 21.2%, 
p=0.002). In addition, CAD was more prevalent in 
those with two or more than two risk factors (72.1% 
versus 7.5%, p<0.001) (Table 4). 
 
Discussion 
The current study elaborates the prevalence of CAD in 
patients with different valvular heart diseases planned 
for corrective surgery. Bozbas et al in their study 
showed 18.8% of patients with rheumatic heart disease 
to have CAD. Not all study patients had undergone 
coronary angiography.12In the study by Chun et al 
26% of patients with mitral stenosis were found to 
have CAD.13 A much higher prevalence rate of 56% 
was found in patients with aortic stenosis by some 
investigators.13Shaikh et al evaluated 144 patients 
undergoing valve surgery and reported severe CAD in 
32.9% of mitral valve and 31.9% of aortic valve 
surgery.14Zeynep YE et al reported prevalence of 
26.4% in MS, 42% in MR and 57.7% in AS.13 In our 
study the overall prevalence of 31.3% was comparable 
to above studies. Also the prevalence according to the 
valve pathology followed same pattern i.e. with mitral 
stenosis 23.3% and with aortic stenosis 43.8%. 
Prevalence in rheumatic heart disease in our study 
was 18.2%. Similarly lower prevalence was reported 
by Marchant et al (14%), Jose et al and Narang et al 
(12.2 and 11% respectively).3,15,16The high prevalence 
(62%) in degenerative valve disease follows the 
findings reported in literature. Lacy et al similarly 
reported 58.9% prevalence of CAD in patients with 
AS.13,17 Similar findings were replicated by Sonmez et 
al.7 
Atherosclerosis plays role in the pathogenesis of 
degenerative valve disease (mostly aortic valve) 
similar to its role in pathogenesis of coronary artery 
disease.13The common pathology is lipid deposition, 
calcification and inflammation.18,19 It has been shown 
that degenerative calcific valve disease is associated 
with 50% increased risk of myocardial infarction and 
death even in absence of significant valve 
dysfunction.19-21 Patients with degenerative valve 
disease are more likely to be older and have more risk 
factors for atherosclerosis than those with other 
etiologies. In particular patients with rheumatic heart 
disease are more likely to be younger and with fewer 
atherosclerotic risk factors. 
Our study showed low prevalence of CAD in patients 
undergoing surgery for valve heart disease.  The 
prevalence was notably lower for rheumatic disease 
patients, pointing towards need for generating 
separate guidelines for developing countries where the 
leading cause for VHD is rheumatic heart disease. The 
patients with degenerative valve lesions however 
should be investigated according to the current 
practices. Furthermore the indication of routine 
preoperative angiogram has level of evidence C, 
meaning it has been based on expert opinions and 
limited studies.9This further emphasizes the need for 
more studies at larger scale. Among those with CAD, 
there was a low percentage (4.2%) found to have 
severe (more than 70% stenosis) CAD. Thus the 
number of patients requiring surgical 
revascularization at the time of valve surgery was 
even lower. The rest will only require risk factor 
modification and medical treatment. Thus probably 
the search for CAD in these patients is often overdone. 
 
Conclusion 
1.Prevalence of coronary artery disease , in valvular 
heart disease patients, is low in rheumatic heart 
disease and high in degenerative valve disease.  
2.Coronary artery disease is significantly more 
common in patients more than 50 years of age or in the 
presence of two or more risk factors. 
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